Sintx Technologies (SINT) Divestments (2018)

Sintx Technologies (SINT) recorded quarterly Divestments of -$76000.0 in Q2 2018, down 145.16% quarter-over-quarter from -$31000.0 in Q1 2018.

Sintx Technologies (SINT) Divestments (2018) Analysis & Trends

Sintx Technologies' Divestments history runs 1 years deep, the most recent figure standing at -$76000.0 for Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.37 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Sintx Technologies 8.59 Mn 6.70 Mn 144,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2018 -76,000.00
Mar 31, 2018 -31,000.00